Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Managing Editor
UK
+7 year(s) experience
HBW Insight
Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year.
HBW Insight
Reckitt Benckiser's TV ad for Nurofen in New Zealand drew numerous complaints for being "socially irresponsible" during the COVID-19 pandemic.
HBW Insight
Bayer posts double-digit rise in Q1 Consumer Health sales off the back of unprecedented demand for its dietary supplements in the middle of the global coronavrius pandemic.
Topic Coronavirus
HBW Insight
Review by MHRA advisory body finds no issue with ibuprofen use in COVID-19 patients and updates advice to recommend either paracetamol or ibuprofen to treat symptoms.
Topic Coronavirus
HBW Insight
Advertising dietary supplements in Poland will incur a new tax under proposals from the country's Ministry of Health. While the government claims the motivation is to promote healthy eating choices, industry says supplements have been unfairly linked to poor dietary choices without evidence.
HBW Insight
Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions.
HBW Insight
An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.
HBW Insight
GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.
HBW Insight
Aspirational OTC products such as probiotics are outstripping demand for traditional symptom relievers, IQVIA's Andy Tisman told the recent Ceuta International Conference. Consumer health players must adapt their portfolios to cater for the more health conscious, informed, and digitally-connected consumer, Tisman advises
Topic Business Strategies
HBW Insight
Recalling Zantac in North America over contamination concerns and tightening regulatory requirements in Europe combined to impede growth at Sanofi Consumer Healthcare in Q3. New CEO Paul Hudson says he is still taking time to get to know the business before making any strategic moves.
Topic Policy and regulation
HBW Insight
Maximizing opportunities from digital technology, addressing environmental concerns and responding to the challenges of Brexit are among the Proprietary Association of Great Britain's top priorities as it enters its second century. The association invited guests from around the world to celebrate its centenary at a gala dinner in London on 17 June.
Topic Brexit Digital Health Strategy
HBW Insight
Bayer Consumer Health's sales declined at a single-digit rate in the first quarter of 2019, as the business continued to battle challenges in Europe and the US. Undeterred by this slow start to the year, the German firm says Consumer Health's performance will begin to turnaround in the coming months.
Topic Business strategies
HBW Insight
31 Jul 2020
HBW Insight
30 Jul 2020
HBW Insight
29 Jul 2020
Pink Sheet
28 Jul 2020
HBW Insight
28 Jul 2020
HBW Insight
27 Jul 2020
HBW Insight
24 Jul 2020
HBW Insight
23 Jul 2020
HBW Insight
23 Jul 2020
HBW Insight
22 Jul 2020
HBW Insight
22 Jul 2020
HBW Insight
21 Jul 2020
HBW Insight
20 Jul 2020
HBW Insight
17 Jul 2020
HBW Insight
17 Jul 2020
